125 related articles for article (PubMed ID: 38053383)
1. ΔNp63 is regulated by insulin/IGF-1 signaling in normal basal/progenitor mammary cells and in luminal-type breast cancer cells.
Stenckova M; Liu Y; Nekulova M; Holcakova J; Pokorna Z; Nenutil R; Thompson AM; Vojtesek B; Coates PJ
Neoplasma; 2023 Oct; 70(5):621-632. PubMed ID: 38053383
[TBL] [Abstract][Full Text] [Related]
2. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER
Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ
J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823
[TBL] [Abstract][Full Text] [Related]
3. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.
Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ
Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932
[TBL] [Abstract][Full Text] [Related]
4. The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer.
Buckley NE; Conlon SJ; Jirstrom K; Kay EW; Crawford NT; O'Grady A; Sheehan K; Mc Dade SS; Wang CW; McCance DJ; Johnston PG; Kennedy RD; Harkin DP; Mullan PB
Cancer Res; 2011 Mar; 71(5):1933-44. PubMed ID: 21363924
[TBL] [Abstract][Full Text] [Related]
5. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates.
Yalcin-Ozuysal O; Fiche M; Guitierrez M; Wagner KU; Raffoul W; Brisken C
Cell Death Differ; 2010 Oct; 17(10):1600-12. PubMed ID: 20379195
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.
Ho JY; Chang FW; Huang FS; Liu JM; Liu YP; Chen SP; Liu YL; Cheng KC; Yu CP; Hsu RJ
PLoS One; 2016; 11(2):e0148301. PubMed ID: 26845172
[TBL] [Abstract][Full Text] [Related]
8. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
[TBL] [Abstract][Full Text] [Related]
10. ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells.
Holcakova J; Nekulova M; Orzol P; Nenutil R; Podhorec J; Svoboda M; Dvorakova P; Pjechova M; Hernychova L; Vojtesek B; Coates PJ
Breast Cancer Res Treat; 2017 Jun; 163(3):475-484. PubMed ID: 28349272
[TBL] [Abstract][Full Text] [Related]
11. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
12. ΔNp63α induces quiescence and downregulates the BRCA1 pathway in estrogen receptor-positive luminal breast cancer cell line MCF7 but not in other breast cancer cell lines.
Amin R; Morita-Fujimura Y; Tawarayama H; Semba K; Chiba N; Fukumoto M; Ikawa S
Mol Oncol; 2016 Apr; 10(4):575-93. PubMed ID: 26704768
[TBL] [Abstract][Full Text] [Related]
13. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
14. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells.
Yanochko GM; Eckhart W
Breast Cancer Res; 2006; 8(2):R18. PubMed ID: 16584539
[TBL] [Abstract][Full Text] [Related]
15. The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity.
Mumcuoglu M; Bagislar S; Yuzugullu H; Alotaibi H; Senturk S; Telkoparan P; Gur-Dedeoglu B; Cingoz B; Bozkurt B; Tazebay UH; Yulug IG; Akcali KC; Ozturk M
PLoS One; 2010 Jun; 5(6):e11288. PubMed ID: 20585577
[TBL] [Abstract][Full Text] [Related]
16. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
17. The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage.
Lindley LE; Curtis KM; Sanchez-Mejias A; Rieger ME; Robbins DJ; Briegel KJ
Development; 2015 Mar; 142(5):893-904. PubMed ID: 25655704
[TBL] [Abstract][Full Text] [Related]
18. Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity.
Chamberlin T; D'Amato JV; Arendt LM
Breast Cancer Res; 2017 Nov; 19(1):128. PubMed ID: 29187227
[TBL] [Abstract][Full Text] [Related]
19. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.
Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J
BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα
Shea MP; O'Leary KA; Fakhraldeen SA; Goffin V; Friedl A; Wisinski KB; Alexander CM; Schuler LA
Cancer Res; 2018 Apr; 78(7):1672-1684. PubMed ID: 29363543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]